Smartphone-delivered Scheduled Smoking With Compliance Facilitation as an Adjunct Cessation Therapy: a Feasibility Study
NCT ID: NCT05763771
Last Updated: 2025-10-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
75 participants
INTERVENTIONAL
2024-02-15
2027-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Use of a Smartphone Mobile Application (App) to Enhance Smoking Cessation Treatment
NCT03519451
Trial of An Innovative Smartphone Intervention for Smoking Cessation
NCT02724462
Smartphone-Delivered Attentional Bias Modification Training in Helping Patients Quit Smoking
NCT02224391
Smartphone Application Smoking Cessation Study
NCT04623736
Partnering With Food Bank to Provide Tobacco Treatment to Underserved Smokers
NCT05004662
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
We propose to develop a mobile smoking intervention termed COmpliance-facilitated Scheduled Smoking Reduction (COSSR) delivered as a smartphone app. Through the proposed research as a pilot study, we want to identify the effect size of the proposed COSSR
intervention. We will pursue the following aims:
Aim 1:
Develop the COSSR app and evaluate the app's usability. In this aim, our first objective is to develop the COSSR app, and our second objective is to evaluate the app's usability, making sure that our app's core features are working, such as generating personalized smoking schedules, recording smoking, and taking carbon monoxide (CO) measures using the portable CO devices. We will recruit 15 participants from across the state of Texas to test our app for 4 weeks.
Aim 2:
Evaluate COSSR's preliminary effects on smoking cessation. In this aim, we will recruit participants (n=60) remotely from across the entire state of Texas to evaluate COSSR's effects on smoking cessation. Participants will be randomly assigned to either the control or the COSSR group. Both groups include the usual care treatment (self-help material and nicotine patches). In the COSSR group, they will use the app to reduce their smoking before quitting, and use 3-week pre-cessation nicotine patches.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Part 1
Participants will use the app for 4 weeks, during which participants will follow a smoking schedule on the app to help you reduce your cigarette consumption
Smart Phone App
Collection of data
NIcotine Patches
Place on the skin
Part 2
Participants will also use the app for the duration of the study (about 3 months).
Participants will be asked to record your smoking using the app and complete online surveys
Smart Phone App
Collection of data
NIcotine Patches
Place on the skin
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Smart Phone App
Collection of data
NIcotine Patches
Place on the skin
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Smoking: an average of 10 or more cigarettes, little cigars, or cigarillos combined per day within the past 30 days preceding the phone screen
* Expired carbon monoxide (CO): \> 6 ppm
* Can install and run the study app on their Android smartphone, or agree to use the study smartphone loaned from the research team
* Agree to return the study smartphone if the participant loans one from the research team
* Willing to reduce smoking (Aim 1)
* Seeking smoking cessation treatment (Aim 2)
* Fluency in spoken and written English
* Agree to be treated via telehealth (live audio-video conference and phone) and to be contacted via text and/or email
* Provide informed consent and agree to all assessments and study procedures
* Willing to refrain from the use of other nicotine/tobacco products for the duration of the study
* Willing to refrain from the use of marijuana, prescription medications not prescribed to the participant, and illegal drugs
Exclusion Criteria
* Meet criteria for a current major depressive episode or suicidality according to the PHQ (indicated by a score of 10 or higher).
* Involved in current and imminent (within the next 45 days) smoking cessation activity
* Women who are pregnant or breastfeeding
* Shares the same address as a currently enrolled participant
* Unwilling to use or allergic to nicotine patches (Aim 2)
* Considered by the investigator to be an unsuitable or unstable candidate, such as those who appear to have cognitive impairment, and those who reside in a shelter, group/recovery facility, or treatment facility
* Any plans to move out of the state in the next 6 months
* Using marijuana, prescription medications not prescribed to the participant, and illegal drugs on a daily basis
* Have experienced abnormal heart rhythms or cardiovascular disease, such as stroke, chest pain, and heart attack, in the last month (Aim 2)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
M.D. Anderson Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yong Cui, PHD
Role: PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
M D Anderson Cancer Center
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Related Links
Access external resources that provide additional context or updates about the study.
M D Anderson Cancer Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2023-01983
Identifier Type: OTHER
Identifier Source: secondary_id
2022-0772
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.